Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antibodies, Viral | 30 | 2023 | 3212 | 3.610 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 8 | 2021 | 163 | 2.640 |
Why?
|
Single-Chain Antibodies | 6 | 2023 | 114 | 2.550 |
Why?
|
Antibodies, Neutralizing | 15 | 2023 | 2010 | 2.210 |
Why?
|
Antibodies | 23 | 2024 | 2421 | 1.930 |
Why?
|
Carbonic Anhydrases | 4 | 2024 | 107 | 1.790 |
Why?
|
HIV Antibodies | 14 | 2014 | 1337 | 1.700 |
Why?
|
Antibodies, Monoclonal | 30 | 2023 | 9244 | 1.670 |
Why?
|
Epitope Mapping | 9 | 2016 | 301 | 1.600 |
Why?
|
Influenza A virus | 6 | 2022 | 455 | 1.520 |
Why?
|
HIV-1 | 32 | 2014 | 6948 | 1.490 |
Why?
|
HIV Envelope Protein gp120 | 14 | 2014 | 923 | 1.490 |
Why?
|
Gene Products, tat | 11 | 2002 | 111 | 1.360 |
Why?
|
Epitopes | 11 | 2023 | 2526 | 1.260 |
Why?
|
Peptide Library | 13 | 2015 | 351 | 1.190 |
Why?
|
Neutralization Tests | 12 | 2022 | 735 | 1.190 |
Why?
|
Human T-lymphotropic virus 1 | 5 | 2008 | 143 | 1.160 |
Why?
|
Genes, Immunoglobulin | 8 | 2023 | 283 | 1.160 |
Why?
|
Immunoglobulin Fragments | 9 | 2010 | 83 | 1.130 |
Why?
|
Influenza A Virus, H5N1 Subtype | 5 | 2016 | 117 | 1.120 |
Why?
|
Carcinoma, Renal Cell | 6 | 2024 | 3186 | 1.070 |
Why?
|
Viral Vaccines | 4 | 2022 | 596 | 1.060 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 2017 | 347 | 1.000 |
Why?
|
Receptors, CCR4 | 3 | 2020 | 77 | 0.970 |
Why?
|
Immunoglobulin Heavy Chains | 11 | 2023 | 647 | 0.970 |
Why?
|
Kidney Neoplasms | 6 | 2024 | 4282 | 0.960 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 13 | 2014 | 119 | 0.910 |
Why?
|
Receptors, Antigen, B-Cell | 2 | 2017 | 546 | 0.880 |
Why?
|
Image Cytometry | 2 | 2020 | 51 | 0.850 |
Why?
|
B-Lymphocytes | 6 | 2017 | 4784 | 0.820 |
Why?
|
Receptors, Interleukin-2 | 6 | 2005 | 565 | 0.790 |
Why?
|
Genitalia, Female | 2 | 2014 | 146 | 0.780 |
Why?
|
Influenza, Human | 7 | 2022 | 1543 | 0.780 |
Why?
|
Influenza A Virus, H1N1 Subtype | 6 | 2022 | 453 | 0.740 |
Why?
|
Viral Envelope Proteins | 9 | 2009 | 640 | 0.740 |
Why?
|
Protein Engineering | 9 | 2015 | 554 | 0.730 |
Why?
|
Receptors, Virus | 6 | 2016 | 652 | 0.730 |
Why?
|
CD4-Positive T-Lymphocytes | 13 | 2012 | 4410 | 0.710 |
Why?
|
Immunity, Humoral | 2 | 2017 | 608 | 0.690 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2012 | 210 | 0.690 |
Why?
|
Antigens, Neoplasm | 4 | 2024 | 1998 | 0.680 |
Why?
|
Antibodies, Bispecific | 1 | 2022 | 204 | 0.670 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 3 | 2008 | 121 | 0.640 |
Why?
|
Influenza Vaccines | 8 | 2021 | 780 | 0.640 |
Why?
|
Severe Acute Respiratory Syndrome | 6 | 2015 | 136 | 0.640 |
Why?
|
Biological Evolution | 3 | 2016 | 1075 | 0.630 |
Why?
|
Immunoglobulin Variable Region | 13 | 2009 | 419 | 0.630 |
Why?
|
Virus Replication | 15 | 2018 | 2457 | 0.630 |
Why?
|
Immunotherapy | 7 | 2024 | 4747 | 0.610 |
Why?
|
Cell Transformation, Viral | 4 | 2008 | 527 | 0.580 |
Why?
|
Flow Cytometry | 17 | 2020 | 5890 | 0.560 |
Why?
|
Gene Expression Regulation, Viral | 5 | 2016 | 434 | 0.560 |
Why?
|
Gene Transfer Techniques | 8 | 2008 | 1206 | 0.560 |
Why?
|
Serum Globulins | 1 | 2016 | 23 | 0.550 |
Why?
|
Peptidyl-Dipeptidase A | 5 | 2016 | 326 | 0.550 |
Why?
|
Amino Acid Sequence | 24 | 2017 | 13411 | 0.540 |
Why?
|
Viral Proteins | 6 | 2022 | 1801 | 0.540 |
Why?
|
Transduction, Genetic | 7 | 2012 | 899 | 0.530 |
Why?
|
Macaca mulatta | 5 | 2016 | 2341 | 0.520 |
Why?
|
Molecular Sequence Data | 27 | 2015 | 17608 | 0.510 |
Why?
|
Immunization, Passive | 2 | 2016 | 618 | 0.500 |
Why?
|
Genetic Vectors | 14 | 2014 | 3401 | 0.500 |
Why?
|
Animals | 89 | 2024 | 168930 | 0.500 |
Why?
|
Coronavirus | 2 | 2015 | 155 | 0.490 |
Why?
|
Coronavirus Infections | 5 | 2016 | 3110 | 0.480 |
Why?
|
Lymphocyte Subsets | 1 | 2016 | 313 | 0.480 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 2 | 2015 | 306 | 0.480 |
Why?
|
Hemagglutination, Viral | 1 | 2014 | 12 | 0.470 |
Why?
|
Neutrophils | 23 | 2012 | 3782 | 0.470 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 2 | 2007 | 167 | 0.470 |
Why?
|
Lentivirus | 3 | 2009 | 518 | 0.470 |
Why?
|
Orthomyxoviridae | 2 | 2017 | 148 | 0.460 |
Why?
|
T-Lymphocytes | 12 | 2024 | 10264 | 0.460 |
Why?
|
Recombinant Proteins | 9 | 2017 | 6507 | 0.460 |
Why?
|
Chemotaxis, Leukocyte | 16 | 1990 | 661 | 0.440 |
Why?
|
Yeasts | 1 | 2015 | 278 | 0.440 |
Why?
|
Receptors, Immunologic | 13 | 1990 | 1418 | 0.430 |
Why?
|
Receptors, Antigen, T-Cell | 4 | 2020 | 2571 | 0.430 |
Why?
|
Dengue | 1 | 2016 | 258 | 0.430 |
Why?
|
Receptors, CXCR4 | 4 | 2007 | 729 | 0.420 |
Why?
|
Gammaretrovirus | 1 | 2012 | 24 | 0.410 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 3114 | 0.410 |
Why?
|
Immunoglobulin Fab Fragments | 5 | 2000 | 446 | 0.410 |
Why?
|
Antibody Specificity | 7 | 2017 | 1062 | 0.400 |
Why?
|
Immunoglobulin Fc Fragments | 2 | 2012 | 287 | 0.400 |
Why?
|
Mice | 36 | 2024 | 81889 | 0.400 |
Why?
|
Genetics, Population | 1 | 2017 | 943 | 0.390 |
Why?
|
Cell Line | 27 | 2020 | 15563 | 0.390 |
Why?
|
Epithelial Cells | 4 | 2016 | 3691 | 0.390 |
Why?
|
Recombinant Fusion Proteins | 13 | 2016 | 3738 | 0.380 |
Why?
|
Bacteriophages | 1 | 2015 | 382 | 0.380 |
Why?
|
Cell Separation | 3 | 2013 | 1718 | 0.370 |
Why?
|
Cell Size | 1 | 2013 | 625 | 0.370 |
Why?
|
Membrane Glycoproteins | 7 | 2008 | 3702 | 0.370 |
Why?
|
Transfection | 14 | 2007 | 5754 | 0.370 |
Why?
|
Transcriptional Activation | 4 | 2007 | 1749 | 0.370 |
Why?
|
MAP Kinase Kinase Kinase 1 | 2 | 2001 | 56 | 0.370 |
Why?
|
Autoantibodies | 2 | 2012 | 2115 | 0.370 |
Why?
|
Humans | 135 | 2024 | 766766 | 0.370 |
Why?
|
Drug Design | 5 | 2018 | 1042 | 0.370 |
Why?
|
Mesenchymal Stem Cells | 2 | 2013 | 1663 | 0.360 |
Why?
|
Models, Molecular | 12 | 2019 | 5386 | 0.360 |
Why?
|
Immunoglobulin G | 8 | 2023 | 4559 | 0.350 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 15 | 1990 | 221 | 0.350 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1105 | 0.350 |
Why?
|
Immunologic Memory | 2 | 2016 | 1377 | 0.340 |
Why?
|
Acquired Immunodeficiency Syndrome | 8 | 2010 | 2205 | 0.340 |
Why?
|
Germ-Line Mutation | 2 | 2023 | 1885 | 0.340 |
Why?
|
Polymorphism, Genetic | 2 | 2020 | 4249 | 0.330 |
Why?
|
Protamines | 3 | 2001 | 112 | 0.330 |
Why?
|
HIV Infections | 13 | 2018 | 17536 | 0.320 |
Why?
|
Virion | 3 | 2009 | 428 | 0.310 |
Why?
|
Cytoplasm | 5 | 2006 | 1505 | 0.310 |
Why?
|
Lymphocytes | 3 | 2015 | 2605 | 0.310 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2017 | 2746 | 0.310 |
Why?
|
Disease Models, Animal | 12 | 2020 | 18330 | 0.300 |
Why?
|
West Nile virus | 4 | 2011 | 77 | 0.300 |
Why?
|
Protein Binding | 12 | 2017 | 9320 | 0.290 |
Why?
|
NF-kappa B | 5 | 2008 | 2493 | 0.290 |
Why?
|
Promoter Regions, Genetic | 3 | 2008 | 5789 | 0.290 |
Why?
|
Gene Products, tax | 1 | 2007 | 51 | 0.290 |
Why?
|
Jurkat Cells | 9 | 2010 | 740 | 0.280 |
Why?
|
Mice, SCID | 4 | 2012 | 2628 | 0.270 |
Why?
|
Neuraminidase | 3 | 2022 | 192 | 0.270 |
Why?
|
Antiviral Agents | 5 | 2022 | 3070 | 0.270 |
Why?
|
Mice, Inbred BALB C | 11 | 2016 | 6222 | 0.270 |
Why?
|
Bone Marrow Cells | 2 | 2013 | 2413 | 0.260 |
Why?
|
Sequence Alignment | 6 | 2020 | 2177 | 0.260 |
Why?
|
Chemotaxis | 3 | 2020 | 598 | 0.260 |
Why?
|
Virus Internalization | 2 | 2010 | 504 | 0.260 |
Why?
|
Virus Diseases | 2 | 2012 | 720 | 0.260 |
Why?
|
Cloning, Molecular | 5 | 2017 | 4168 | 0.250 |
Why?
|
Chemotactic Factors | 5 | 1990 | 197 | 0.250 |
Why?
|
Gene Silencing | 3 | 2008 | 1504 | 0.250 |
Why?
|
Binding Sites | 10 | 2017 | 6012 | 0.250 |
Why?
|
Chiroptera | 2 | 2016 | 62 | 0.250 |
Why?
|
Dipeptidyl Peptidase 4 | 2 | 2016 | 93 | 0.250 |
Why?
|
Drug Resistance, Viral | 2 | 2022 | 868 | 0.240 |
Why?
|
Genes, MHC Class I | 2 | 2004 | 236 | 0.240 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2016 | 792 | 0.240 |
Why?
|
Immunotoxins | 2 | 1996 | 175 | 0.240 |
Why?
|
Antineoplastic Agents | 3 | 2018 | 13643 | 0.240 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2010 | 504 | 0.240 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1642 | 0.230 |
Why?
|
Crystallography, X-Ray | 5 | 2017 | 1947 | 0.230 |
Why?
|
Antibody Diversity | 1 | 2023 | 72 | 0.220 |
Why?
|
Selection, Genetic | 1 | 2008 | 878 | 0.220 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2016 | 4652 | 0.220 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 2 | 2016 | 103 | 0.220 |
Why?
|
Chimera | 3 | 2016 | 455 | 0.220 |
Why?
|
Viral Matrix Proteins | 2 | 2008 | 193 | 0.220 |
Why?
|
Gene Expression | 9 | 2017 | 7585 | 0.220 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2007 | 658 | 0.220 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2023 | 58 | 0.220 |
Why?
|
Hemagglutinins, Viral | 2 | 2015 | 66 | 0.220 |
Why?
|
Communicable Diseases, Emerging | 2 | 2016 | 149 | 0.210 |
Why?
|
HeLa Cells | 5 | 2014 | 3073 | 0.210 |
Why?
|
Oseltamivir | 2 | 2022 | 76 | 0.210 |
Why?
|
HIV Long Terminal Repeat | 3 | 2001 | 86 | 0.210 |
Why?
|
Protein Conformation | 7 | 2016 | 3947 | 0.210 |
Why?
|
DNA-Binding Proteins | 5 | 2004 | 9611 | 0.200 |
Why?
|
Antigens, Viral | 2 | 2020 | 995 | 0.200 |
Why?
|
Cells, Cultured | 9 | 2020 | 18984 | 0.200 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 1646 | 0.200 |
Why?
|
Cell Line, Tumor | 8 | 2020 | 17088 | 0.200 |
Why?
|
Viral Fusion Proteins | 2 | 2015 | 100 | 0.200 |
Why?
|
Cell Membrane | 6 | 2008 | 3641 | 0.200 |
Why?
|
Membrane Proteins | 3 | 2015 | 7868 | 0.200 |
Why?
|
HIV Antigens | 3 | 1998 | 328 | 0.200 |
Why?
|
Cricetinae | 3 | 2022 | 2416 | 0.200 |
Why?
|
Receptors, Transferrin | 1 | 2003 | 300 | 0.190 |
Why?
|
Phylogeny | 5 | 2018 | 2840 | 0.190 |
Why?
|
Receptors, Formyl Peptide | 15 | 1990 | 146 | 0.190 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2004 | 457 | 0.190 |
Why?
|
Plasmids | 3 | 2001 | 2268 | 0.190 |
Why?
|
Protein Sorting Signals | 2 | 2008 | 274 | 0.190 |
Why?
|
Base Sequence | 12 | 2010 | 12415 | 0.190 |
Why?
|
Ovarian Neoplasms | 2 | 2018 | 4904 | 0.180 |
Why?
|
Drug Industry | 1 | 2007 | 791 | 0.180 |
Why?
|
Genes, erbB-2 | 1 | 2001 | 161 | 0.180 |
Why?
|
Adenoviridae | 1 | 2005 | 1093 | 0.180 |
Why?
|
I-kappa B Proteins | 1 | 2001 | 210 | 0.180 |
Why?
|
Protein Structure, Quaternary | 2 | 2014 | 423 | 0.180 |
Why?
|
Orthomyxoviridae Infections | 2 | 2016 | 255 | 0.180 |
Why?
|
Oligopeptides | 7 | 1995 | 1195 | 0.180 |
Why?
|
Chemokine CCL22 | 1 | 2020 | 27 | 0.170 |
Why?
|
Dependovirus | 3 | 2014 | 720 | 0.170 |
Why?
|
Cyclins | 1 | 2002 | 605 | 0.170 |
Why?
|
Cell Line, Transformed | 6 | 2004 | 861 | 0.170 |
Why?
|
Chemokine CCL17 | 1 | 2020 | 26 | 0.170 |
Why?
|
Ebolavirus | 1 | 2002 | 250 | 0.170 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2000 | 2902 | 0.170 |
Why?
|
alpha-Galactosidase | 1 | 2020 | 58 | 0.170 |
Why?
|
Orthopedic Procedures | 1 | 2010 | 1279 | 0.170 |
Why?
|
Antibody Affinity | 3 | 2016 | 251 | 0.170 |
Why?
|
Cell Proliferation | 4 | 2020 | 10445 | 0.160 |
Why?
|
Protein Processing, Post-Translational | 1 | 2007 | 1964 | 0.160 |
Why?
|
HEK293 Cells | 4 | 2018 | 4276 | 0.160 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2015 | 3804 | 0.160 |
Why?
|
Hematopoiesis | 1 | 2008 | 2060 | 0.160 |
Why?
|
Lung | 4 | 2016 | 10067 | 0.160 |
Why?
|
N-Formylmethionine | 4 | 1983 | 14 | 0.160 |
Why?
|
Interleukin-2 | 3 | 2007 | 1895 | 0.160 |
Why?
|
Immunoglobulin Light Chains | 4 | 2004 | 289 | 0.160 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 1331 | 0.150 |
Why?
|
Amino Acid Substitution | 3 | 2018 | 1742 | 0.150 |
Why?
|
Forecasting | 1 | 2007 | 2936 | 0.150 |
Why?
|
Keratinocytes | 2 | 2004 | 876 | 0.150 |
Why?
|
Receptors, CCR5 | 4 | 2003 | 491 | 0.150 |
Why?
|
Galactosyltransferases | 1 | 2020 | 283 | 0.150 |
Why?
|
Neoplasms | 6 | 2020 | 22350 | 0.150 |
Why?
|
Dengue Virus | 3 | 2016 | 204 | 0.150 |
Why?
|
Alleles | 3 | 2023 | 6895 | 0.150 |
Why?
|
DNA Primers | 6 | 2012 | 2826 | 0.150 |
Why?
|
Peptides | 2 | 2009 | 4344 | 0.150 |
Why?
|
Binding Sites, Antibody | 4 | 2009 | 340 | 0.150 |
Why?
|
Up-Regulation | 3 | 2004 | 4142 | 0.150 |
Why?
|
Cross Reactions | 4 | 2016 | 826 | 0.140 |
Why?
|
Tumor Cells, Cultured | 6 | 2007 | 6104 | 0.140 |
Why?
|
Pentoxifylline | 1 | 1997 | 53 | 0.140 |
Why?
|
Oncogene Proteins | 3 | 1996 | 715 | 0.140 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2018 | 133 | 0.140 |
Why?
|
West Nile Fever | 2 | 2009 | 77 | 0.140 |
Why?
|
Mutant Proteins | 3 | 2016 | 487 | 0.140 |
Why?
|
Antibody-Dependent Enhancement | 1 | 2016 | 15 | 0.140 |
Why?
|
Genetic Fitness | 1 | 2018 | 120 | 0.140 |
Why?
|
HIV Seropositivity | 2 | 1995 | 962 | 0.140 |
Why?
|
Bacterial Toxins | 2 | 1995 | 922 | 0.140 |
Why?
|
Zoonoses | 2 | 2016 | 180 | 0.140 |
Why?
|
Giant Cells | 3 | 2004 | 187 | 0.130 |
Why?
|
Coronaviridae | 1 | 2016 | 13 | 0.130 |
Why?
|
Skin Transplantation | 1 | 2002 | 1097 | 0.130 |
Why?
|
Dogs | 5 | 2019 | 3834 | 0.130 |
Why?
|
Killer Cells, Natural | 2 | 2016 | 2210 | 0.130 |
Why?
|
Coronaviridae Infections | 1 | 2016 | 10 | 0.130 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 2 | 2010 | 149 | 0.130 |
Why?
|
Gene Products, gag | 1 | 1997 | 317 | 0.130 |
Why?
|
Blotting, Western | 3 | 2012 | 5022 | 0.130 |
Why?
|
Carbazoles | 1 | 1997 | 230 | 0.130 |
Why?
|
Portraits as Topic | 1 | 2015 | 33 | 0.120 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2017 | 447 | 0.120 |
Why?
|
Virus Attachment | 1 | 2015 | 56 | 0.120 |
Why?
|
Leukemia Virus, Murine | 3 | 2009 | 95 | 0.120 |
Why?
|
Proteome | 1 | 2005 | 1894 | 0.120 |
Why?
|
ADP Ribose Transferases | 1 | 1995 | 90 | 0.120 |
Why?
|
Glycoproteins | 1 | 2002 | 2201 | 0.120 |
Why?
|
Genotype | 3 | 2017 | 13036 | 0.120 |
Why?
|
K562 Cells | 1 | 2016 | 645 | 0.120 |
Why?
|
Exotoxins | 1 | 1995 | 123 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 2 | 2020 | 1504 | 0.120 |
Why?
|
Gene Duplication | 1 | 2016 | 315 | 0.120 |
Why?
|
Protein Structure, Secondary | 1 | 2017 | 1211 | 0.120 |
Why?
|
Methionine | 3 | 1982 | 569 | 0.120 |
Why?
|
Granzymes | 1 | 2016 | 278 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2004 | 2426 | 0.120 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2015 | 174 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2004 | 2430 | 0.110 |
Why?
|
Haplotypes | 1 | 2020 | 2727 | 0.110 |
Why?
|
Trans-Activators | 1 | 2004 | 2855 | 0.110 |
Why?
|
Repressor Proteins | 2 | 2004 | 2978 | 0.110 |
Why?
|
Virulence | 2 | 2015 | 1294 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 938 | 0.110 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 630 | 0.110 |
Why?
|
Kinetics | 10 | 2010 | 6287 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2885 | 0.110 |
Why?
|
Centrifugation | 1 | 2013 | 121 | 0.110 |
Why?
|
Viremia | 1 | 2016 | 727 | 0.110 |
Why?
|
Cell Nucleolus | 1 | 1994 | 156 | 0.110 |
Why?
|
Protein Biosynthesis | 1 | 2000 | 2093 | 0.110 |
Why?
|
Receptors, Cell Surface | 6 | 2007 | 2815 | 0.110 |
Why?
|
Receptors, IgG | 1 | 2016 | 562 | 0.110 |
Why?
|
Immunophenotyping | 3 | 2015 | 1867 | 0.100 |
Why?
|
Cell Fractionation | 1 | 2013 | 245 | 0.100 |
Why?
|
Leukocytes, Mononuclear | 4 | 2022 | 1852 | 0.100 |
Why?
|
Surface Plasmon Resonance | 2 | 2012 | 268 | 0.100 |
Why?
|
Nuclear Proteins | 2 | 2000 | 5795 | 0.100 |
Why?
|
Monocytes | 3 | 2014 | 2600 | 0.100 |
Why?
|
Gelatinases | 1 | 2012 | 93 | 0.100 |
Why?
|
Immune Sera | 3 | 2008 | 605 | 0.100 |
Why?
|
Luciferases | 2 | 2007 | 713 | 0.100 |
Why?
|
Clinical Protocols | 1 | 1998 | 1437 | 0.100 |
Why?
|
DNA | 3 | 1996 | 7208 | 0.100 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2012 | 89 | 0.100 |
Why?
|
Kidney | 3 | 2005 | 7074 | 0.100 |
Why?
|
COS Cells | 4 | 2005 | 1135 | 0.100 |
Why?
|
Ethanol | 1 | 2018 | 1326 | 0.100 |
Why?
|
Combined Modality Therapy | 1 | 2024 | 8540 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1791 | 0.090 |
Why?
|
Species Specificity | 2 | 2016 | 2413 | 0.090 |
Why?
|
Gene Dosage | 1 | 2016 | 1211 | 0.090 |
Why?
|
Thymus Gland | 2 | 2018 | 1260 | 0.090 |
Why?
|
Lymphocyte Transfusion | 1 | 2012 | 236 | 0.090 |
Why?
|
Virulence Factors | 1 | 1995 | 498 | 0.090 |
Why?
|
Fetal Tissue Transplantation | 1 | 2011 | 139 | 0.090 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2015 | 548 | 0.090 |
Why?
|
Pyrroles | 1 | 1997 | 1121 | 0.090 |
Why?
|
Lentiviruses, Primate | 1 | 2010 | 6 | 0.090 |
Why?
|
Immunization | 3 | 2011 | 1218 | 0.090 |
Why?
|
Rabbits | 11 | 1989 | 4752 | 0.090 |
Why?
|
Immune Evasion | 1 | 2014 | 375 | 0.090 |
Why?
|
Endocytosis | 1 | 2015 | 951 | 0.090 |
Why?
|
Phytohemagglutinins | 2 | 2003 | 164 | 0.090 |
Why?
|
Viral Load | 2 | 2018 | 3385 | 0.090 |
Why?
|
Gene Products, env | 1 | 2011 | 250 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2008 | 11920 | 0.090 |
Why?
|
Cell Nucleus | 3 | 2000 | 2870 | 0.090 |
Why?
|
GRB2 Adaptor Protein | 2 | 2000 | 101 | 0.090 |
Why?
|
Mutation | 6 | 2022 | 30213 | 0.090 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2013 | 633 | 0.090 |
Why?
|
HLA-C Antigens | 1 | 2010 | 146 | 0.090 |
Why?
|
Escherichia coli | 4 | 2005 | 4211 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2198 | 0.090 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2010 | 105 | 0.090 |
Why?
|
Catalytic Domain | 2 | 2010 | 699 | 0.080 |
Why?
|
Drug Discovery | 1 | 2018 | 1065 | 0.080 |
Why?
|
Cat-Scratch Disease | 1 | 1989 | 23 | 0.080 |
Why?
|
Cations, Monovalent | 1 | 1989 | 24 | 0.080 |
Why?
|
Cell Extracts | 1 | 2010 | 134 | 0.080 |
Why?
|
Biotinylation | 1 | 2010 | 184 | 0.080 |
Why?
|
Polymerase Chain Reaction | 3 | 2012 | 6066 | 0.080 |
Why?
|
Pheromones | 1 | 1990 | 93 | 0.080 |
Why?
|
Gene Library | 2 | 2020 | 1065 | 0.080 |
Why?
|
Guanine Nucleotides | 1 | 1989 | 55 | 0.080 |
Why?
|
Protein Isoforms | 2 | 2007 | 1716 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3607 | 0.080 |
Why?
|
Transgenes | 3 | 2001 | 1014 | 0.080 |
Why?
|
Complement System Proteins | 1 | 2012 | 738 | 0.080 |
Why?
|
Indoles | 1 | 1997 | 1834 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2005 | 9525 | 0.080 |
Why?
|
Octamer Transcription Factor-1 | 1 | 2008 | 30 | 0.080 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 381 | 0.080 |
Why?
|
Proteins | 2 | 2000 | 6002 | 0.080 |
Why?
|
Antibody Formation | 3 | 2005 | 1392 | 0.080 |
Why?
|
Down-Regulation | 3 | 2004 | 2931 | 0.080 |
Why?
|
Graft Rejection | 1 | 2002 | 4504 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2015 | 11061 | 0.080 |
Why?
|
Viruses | 1 | 2012 | 371 | 0.080 |
Why?
|
Viral Interference | 1 | 2008 | 11 | 0.080 |
Why?
|
Enterococcus faecalis | 1 | 1990 | 244 | 0.080 |
Why?
|
Computational Biology | 1 | 2020 | 3564 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2012 | 1677 | 0.080 |
Why?
|
Sp1 Transcription Factor | 1 | 2008 | 143 | 0.070 |
Why?
|
Complementarity Determining Regions | 1 | 2008 | 154 | 0.070 |
Why?
|
Immunoglobulin Idiotypes | 2 | 1992 | 200 | 0.070 |
Why?
|
Cysteine Endopeptidases | 2 | 2001 | 542 | 0.070 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 1987 | 64 | 0.070 |
Why?
|
AIDS Vaccines | 1 | 1994 | 898 | 0.070 |
Why?
|
Genetic Loci | 1 | 2017 | 2630 | 0.070 |
Why?
|
Mice, Inbred NOD | 1 | 2012 | 1838 | 0.070 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2008 | 85 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2746 | 0.070 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 1995 | 1354 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2015 | 1627 | 0.070 |
Why?
|
Coronavirus 229E, Human | 1 | 2007 | 18 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2012 | 6214 | 0.070 |
Why?
|
Postoperative Complications | 1 | 2010 | 15831 | 0.070 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2012 | 614 | 0.070 |
Why?
|
Serine Endopeptidases | 1 | 2012 | 1027 | 0.070 |
Why?
|
Female | 20 | 2020 | 396520 | 0.070 |
Why?
|
RNA, Small Interfering | 2 | 2008 | 3425 | 0.070 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2007 | 97 | 0.070 |
Why?
|
Endosomes | 1 | 2010 | 521 | 0.070 |
Why?
|
Apoptosis | 4 | 2006 | 9513 | 0.070 |
Why?
|
Autoimmunity | 1 | 2015 | 1358 | 0.070 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2010 | 827 | 0.070 |
Why?
|
Protein Phosphatase 1 | 1 | 2007 | 135 | 0.070 |
Why?
|
Cytidine Deaminase | 1 | 2008 | 249 | 0.070 |
Why?
|
Crows | 1 | 2006 | 5 | 0.070 |
Why?
|
Histone Deacetylase 1 | 1 | 2007 | 133 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3944 | 0.070 |
Why?
|
Genetic Variation | 2 | 2020 | 6612 | 0.070 |
Why?
|
Hydroxamic Acids | 2 | 2006 | 483 | 0.070 |
Why?
|
Regenerative Medicine | 1 | 2010 | 304 | 0.070 |
Why?
|
Ibuprofen | 1 | 1987 | 228 | 0.070 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2008 | 501 | 0.060 |
Why?
|
Receptors, Complement | 1 | 1986 | 254 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2007 | 420 | 0.060 |
Why?
|
Fluoroscopy | 1 | 2010 | 948 | 0.060 |
Why?
|
Genetic Techniques | 1 | 2008 | 428 | 0.060 |
Why?
|
Antigen-Presenting Cells | 1 | 2009 | 960 | 0.060 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2005 | 40 | 0.060 |
Why?
|
Cell Lineage | 2 | 2013 | 2572 | 0.060 |
Why?
|
Molecular Targeted Therapy | 2 | 2014 | 2823 | 0.060 |
Why?
|
Transplantation, Heterologous | 3 | 2020 | 2391 | 0.060 |
Why?
|
Chemokine CXCL12 | 1 | 2007 | 457 | 0.060 |
Why?
|
Hyperkalemia | 1 | 1987 | 233 | 0.060 |
Why?
|
Affinity Labels | 1 | 1985 | 107 | 0.060 |
Why?
|
Carcinoma 256, Walker | 1 | 1985 | 37 | 0.060 |
Why?
|
Boronic Acids | 2 | 2006 | 915 | 0.060 |
Why?
|
Antigen Presentation | 1 | 2010 | 1250 | 0.060 |
Why?
|
Pandemics | 2 | 2023 | 8735 | 0.060 |
Why?
|
Carboxypeptidases | 1 | 2005 | 121 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2013 | 11651 | 0.060 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2009 | 1442 | 0.060 |
Why?
|
Anti-HIV Agents | 2 | 1998 | 4562 | 0.060 |
Why?
|
Transplantation, Autologous | 1 | 2010 | 2127 | 0.060 |
Why?
|
Receptors, Peptide | 1 | 2006 | 280 | 0.060 |
Why?
|
Immunoprecipitation | 1 | 2007 | 874 | 0.060 |
Why?
|
Transcription Factors | 2 | 2004 | 12150 | 0.060 |
Why?
|
Endopeptidases | 2 | 2012 | 762 | 0.060 |
Why?
|
Detergents | 1 | 1985 | 235 | 0.060 |
Why?
|
Surface-Active Agents | 1 | 1985 | 150 | 0.060 |
Why?
|
Proteinuria | 1 | 1987 | 613 | 0.060 |
Why?
|
Transplantation, Homologous | 2 | 2004 | 4860 | 0.060 |
Why?
|
Respiratory Tract Infections | 1 | 2012 | 1008 | 0.060 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1986 | 415 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2007 | 856 | 0.060 |
Why?
|
Acetylation | 1 | 2007 | 1054 | 0.060 |
Why?
|
Liver Transplantation | 2 | 2018 | 2416 | 0.060 |
Why?
|
Time Factors | 6 | 2012 | 40149 | 0.060 |
Why?
|
Gene Rearrangement | 3 | 1995 | 1142 | 0.060 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2005 | 199 | 0.060 |
Why?
|
RNA Polymerase II | 1 | 2008 | 549 | 0.060 |
Why?
|
Recombination, Genetic | 2 | 2016 | 1525 | 0.060 |
Why?
|
Sequence Analysis, Protein | 1 | 2005 | 261 | 0.060 |
Why?
|
Hybridomas | 1 | 2005 | 442 | 0.060 |
Why?
|
Evolution, Molecular | 2 | 2018 | 1892 | 0.060 |
Why?
|
CpG Islands | 1 | 2008 | 1208 | 0.060 |
Why?
|
Janus Kinase 3 | 1 | 2004 | 75 | 0.050 |
Why?
|
Janus Kinase 1 | 1 | 2004 | 108 | 0.050 |
Why?
|
Cell Movement | 2 | 2015 | 5199 | 0.050 |
Why?
|
HTLV-I Infections | 1 | 2004 | 104 | 0.050 |
Why?
|
Disease Progression | 1 | 2020 | 13640 | 0.050 |
Why?
|
Pyrazines | 2 | 2006 | 1204 | 0.050 |
Why?
|
Hemagglutinins | 2 | 2017 | 111 | 0.050 |
Why?
|
Concanavalin A | 1 | 2003 | 189 | 0.050 |
Why?
|
Cyclin T | 1 | 2002 | 19 | 0.050 |
Why?
|
Moloney murine leukemia virus | 1 | 2003 | 110 | 0.050 |
Why?
|
Vaccines | 1 | 2011 | 842 | 0.050 |
Why?
|
GTP Phosphohydrolases | 1 | 1986 | 525 | 0.050 |
Why?
|
Immunoglobulin kappa-Chains | 2 | 1994 | 171 | 0.050 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2004 | 178 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2005 | 4349 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2005 | 588 | 0.050 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1995 | 2184 | 0.050 |
Why?
|
Histone Deacetylases | 1 | 2007 | 712 | 0.050 |
Why?
|
Blood Transfusion, Autologous | 1 | 2003 | 130 | 0.050 |
Why?
|
Cell Survival | 1 | 2012 | 5748 | 0.050 |
Why?
|
Macrophages | 3 | 2014 | 5783 | 0.050 |
Why?
|
GTP-Binding Proteins | 1 | 1986 | 946 | 0.050 |
Why?
|
Cell Division | 3 | 1999 | 4474 | 0.050 |
Why?
|
Artificial Gene Fusion | 1 | 2001 | 56 | 0.050 |
Why?
|
Culture Media, Conditioned | 1 | 2003 | 520 | 0.050 |
Why?
|
Macaca | 1 | 2003 | 413 | 0.050 |
Why?
|
Caspases | 2 | 2006 | 881 | 0.050 |
Why?
|
Retroviruses, Simian | 1 | 2001 | 12 | 0.050 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2006 | 776 | 0.050 |
Why?
|
Indicators and Reagents | 2 | 1995 | 456 | 0.050 |
Why?
|
Immediate-Early Proteins | 1 | 2004 | 444 | 0.050 |
Why?
|
Tetracycline | 1 | 2001 | 216 | 0.040 |
Why?
|
Gene Products, nef | 1 | 2000 | 101 | 0.040 |
Why?
|
Terminal Repeat Sequences | 1 | 2000 | 70 | 0.040 |
Why?
|
Cytosol | 1 | 2004 | 887 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 2 | 2018 | 2586 | 0.040 |
Why?
|
Intubation | 1 | 2020 | 140 | 0.040 |
Why?
|
Methionine Sulfoximine | 1 | 2000 | 12 | 0.040 |
Why?
|
Proteolipids | 1 | 2000 | 109 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 2011 | 2678 | 0.040 |
Why?
|
Binding, Competitive | 4 | 1989 | 1141 | 0.040 |
Why?
|
Genomic Structural Variation | 1 | 2020 | 80 | 0.040 |
Why?
|
Substance P | 1 | 1981 | 331 | 0.040 |
Why?
|
Data Display | 1 | 2020 | 174 | 0.040 |
Why?
|
Protein Structure, Tertiary | 4 | 2009 | 3757 | 0.040 |
Why?
|
Limit of Detection | 1 | 2020 | 271 | 0.040 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2000 | 76 | 0.040 |
Why?
|
Transplantation Immunology | 1 | 2002 | 540 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2004 | 872 | 0.040 |
Why?
|
Intracellular Fluid | 2 | 1999 | 201 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2020 | 1057 | 0.040 |
Why?
|
Superoxides | 6 | 1988 | 388 | 0.040 |
Why?
|
Rats | 10 | 2005 | 23717 | 0.040 |
Why?
|
Blood Platelets | 1 | 2010 | 2465 | 0.040 |
Why?
|
RNA Interference | 1 | 2008 | 2827 | 0.040 |
Why?
|
Transcription Factor AP-1 | 1 | 2000 | 321 | 0.040 |
Why?
|
Phenotype | 2 | 2013 | 16724 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 1982 | 931 | 0.040 |
Why?
|
Phosphoproteins | 2 | 2020 | 2448 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2016 | 16044 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2001 | 697 | 0.040 |
Why?
|
NFATC Transcription Factors | 1 | 2000 | 392 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2004 | 12791 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 1405 | 0.040 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 1998 | 93 | 0.040 |
Why?
|
Virulence Factors, Bordetella | 2 | 1989 | 154 | 0.040 |
Why?
|
Cytoskeletal Proteins | 1 | 2004 | 1325 | 0.040 |
Why?
|
Pertussis Toxin | 2 | 1989 | 176 | 0.040 |
Why?
|
Adult | 11 | 2020 | 223307 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2020 | 526 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2001 | 663 | 0.040 |
Why?
|
Male | 13 | 2020 | 364142 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 1988 | 1528 | 0.040 |
Why?
|
Cyclosporine | 1 | 2000 | 778 | 0.040 |
Why?
|
Signal Transduction | 3 | 2010 | 23619 | 0.040 |
Why?
|
Pancreatic Neoplasms | 2 | 2006 | 5444 | 0.040 |
Why?
|
Muscle Contraction | 1 | 1982 | 1208 | 0.040 |
Why?
|
Liposomes | 1 | 2001 | 787 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2001 | 1525 | 0.040 |
Why?
|
rev Gene Products, Human Immunodeficiency Virus | 1 | 1997 | 26 | 0.040 |
Why?
|
Gene Products, rev | 1 | 1997 | 29 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 1999 | 656 | 0.040 |
Why?
|
Protein Subunits | 1 | 2020 | 940 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2011 | 5503 | 0.030 |
Why?
|
CHO Cells | 1 | 2000 | 1376 | 0.030 |
Why?
|
Organisms, Genetically Modified | 1 | 2016 | 63 | 0.030 |
Why?
|
HIV Envelope Protein gp160 | 1 | 1997 | 95 | 0.030 |
Why?
|
Nucleocapsid Proteins | 1 | 1997 | 75 | 0.030 |
Why?
|
Vaccines, Inactivated | 1 | 2017 | 186 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4570 | 0.030 |
Why?
|
Homeostasis | 1 | 2007 | 3342 | 0.030 |
Why?
|
Survival Analysis | 1 | 2009 | 10100 | 0.030 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 1997 | 213 | 0.030 |
Why?
|
Host Specificity | 1 | 2016 | 56 | 0.030 |
Why?
|
HIV Reverse Transcriptase | 1 | 1997 | 214 | 0.030 |
Why?
|
Liver | 1 | 2011 | 7571 | 0.030 |
Why?
|
Encephalitis, Viral | 1 | 2016 | 58 | 0.030 |
Why?
|
Lysosomes | 4 | 1988 | 937 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2000 | 1729 | 0.030 |
Why?
|
HIV Integrase | 1 | 1997 | 122 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2012 | 8926 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 859 | 0.030 |
Why?
|
Cholera Toxin | 2 | 1989 | 562 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 1988 | 355 | 0.030 |
Why?
|
Acute Kidney Injury | 1 | 1987 | 1946 | 0.030 |
Why?
|
Glioblastoma | 1 | 2010 | 3458 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2007 | 2254 | 0.030 |
Why?
|
Complement C5 | 2 | 1986 | 104 | 0.030 |
Why?
|
Receptors, Somatotropin | 1 | 1995 | 58 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20144 | 0.030 |
Why?
|
Vero Cells | 1 | 2016 | 486 | 0.030 |
Why?
|
Leukemia, T-Cell | 1 | 1995 | 102 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2001 | 1319 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2004 | 1884 | 0.030 |
Why?
|
Virus Integration | 1 | 1997 | 307 | 0.030 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 1998 | 497 | 0.030 |
Why?
|
U937 Cells | 1 | 2014 | 260 | 0.030 |
Why?
|
Receptors, Growth Factor | 1 | 1995 | 324 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 1995 | 383 | 0.030 |
Why?
|
DNA Methylation | 1 | 2008 | 4427 | 0.030 |
Why?
|
Gene Deletion | 1 | 2002 | 2669 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2018 | 1044 | 0.030 |
Why?
|
Coculture Techniques | 1 | 1998 | 1337 | 0.030 |
Why?
|
bcl-X Protein | 2 | 2006 | 412 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2020 | 1409 | 0.030 |
Why?
|
Prevalence | 1 | 2011 | 15835 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2001 | 21162 | 0.030 |
Why?
|
Prostaglandins E | 2 | 1984 | 166 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2005 | 2210 | 0.030 |
Why?
|
Rats, Inbred Strains | 3 | 1985 | 2078 | 0.030 |
Why?
|
Microscopy, Immunoelectron | 1 | 1994 | 316 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 1996 | 2470 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2000 | 1491 | 0.030 |
Why?
|
Biotechnology | 1 | 1995 | 283 | 0.030 |
Why?
|
Models, Structural | 1 | 1993 | 339 | 0.030 |
Why?
|
Solubility | 2 | 1985 | 1078 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2015 | 928 | 0.030 |
Why?
|
Societies, Scientific | 1 | 2014 | 221 | 0.030 |
Why?
|
Directed Molecular Evolution | 1 | 2014 | 167 | 0.030 |
Why?
|
Molecular Weight | 2 | 1985 | 2168 | 0.030 |
Why?
|
Cancer Vaccines | 1 | 2020 | 1042 | 0.020 |
Why?
|
Virology | 1 | 2012 | 76 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1993 | 705 | 0.020 |
Why?
|
Goats | 2 | 1982 | 166 | 0.020 |
Why?
|
Drug Synergism | 2 | 2006 | 1756 | 0.020 |
Why?
|
Fibroblasts | 1 | 2002 | 4166 | 0.020 |
Why?
|
Benzodiazepines | 1 | 1997 | 1137 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2039 | 0.020 |
Why?
|
Transferrin | 2 | 1982 | 283 | 0.020 |
Why?
|
Toxoplasmosis | 1 | 1991 | 94 | 0.020 |
Why?
|
Middle Aged | 7 | 2020 | 223257 | 0.020 |
Why?
|
Point Mutation | 1 | 2016 | 1591 | 0.020 |
Why?
|
Guinea Pigs | 2 | 1982 | 1309 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2004 | 4924 | 0.020 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 2011 | 84 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2018 | 2730 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 1995 | 754 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
Systems Biology | 1 | 2014 | 481 | 0.020 |
Why?
|
Epidemics | 1 | 2015 | 516 | 0.020 |
Why?
|
Family | 1 | 2020 | 3209 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4780 | 0.020 |
Why?
|
HLA-B Antigens | 1 | 2010 | 330 | 0.020 |
Why?
|
Complement C5a | 2 | 1986 | 100 | 0.020 |
Why?
|
Exons | 1 | 1995 | 2392 | 0.020 |
Why?
|
Endoplasmic Reticulum | 1 | 1995 | 1132 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2010 | 9101 | 0.020 |
Why?
|
Tritium | 1 | 1989 | 707 | 0.020 |
Why?
|
Guanosine Triphosphate | 1 | 1989 | 315 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2018 | 5753 | 0.020 |
Why?
|
Cattle | 2 | 2006 | 3815 | 0.020 |
Why?
|
Zanamivir | 1 | 2008 | 21 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2010 | 39309 | 0.020 |
Why?
|
Autoradiography | 2 | 1989 | 725 | 0.020 |
Why?
|
Colony-Stimulating Factors | 1 | 1988 | 218 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2005 | 8621 | 0.020 |
Why?
|
HIV | 1 | 1995 | 1588 | 0.020 |
Why?
|
Swine | 1 | 2018 | 5987 | 0.020 |
Why?
|
Chromatography, Ion Exchange | 1 | 1988 | 292 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2000 | 4215 | 0.020 |
Why?
|
Microscopy, Phase-Contrast | 1 | 1987 | 110 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 1988 | 861 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 1988 | 634 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3799 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22352 | 0.020 |
Why?
|
Hexosaminidases | 1 | 1986 | 45 | 0.020 |
Why?
|
Acetylglucosaminidase | 2 | 1984 | 66 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2012 | 865 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 3 | 2000 | 361 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1985 | 826 | 0.020 |
Why?
|
Phospholipases | 1 | 1986 | 75 | 0.020 |
Why?
|
Streptococcal Infections | 1 | 1991 | 618 | 0.020 |
Why?
|
Acetophenones | 1 | 1986 | 52 | 0.020 |
Why?
|
Reverse Transcription | 1 | 2006 | 48 | 0.020 |
Why?
|
Patient Selection | 1 | 1998 | 4252 | 0.020 |
Why?
|
Growth Substances | 1 | 1988 | 759 | 0.020 |
Why?
|
Microscopy, Electron | 2 | 2005 | 2551 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 1994 | 1927 | 0.020 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 2006 | 48 | 0.020 |
Why?
|
Ions | 1 | 1986 | 254 | 0.020 |
Why?
|
Aged | 3 | 2020 | 171343 | 0.020 |
Why?
|
Phospholipases A | 1 | 1986 | 204 | 0.020 |
Why?
|
Viverridae | 1 | 2005 | 6 | 0.020 |
Why?
|
Crystallization | 1 | 2006 | 518 | 0.020 |
Why?
|
Leukotriene B4 | 1 | 1986 | 281 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 14072 | 0.020 |
Why?
|
Quinones | 1 | 2005 | 79 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2006 | 304 | 0.010 |
Why?
|
Pilot Projects | 1 | 1998 | 8728 | 0.010 |
Why?
|
Receptors, HIV | 1 | 2005 | 159 | 0.010 |
Why?
|
Filtration | 1 | 1985 | 227 | 0.010 |
Why?
|
Benzoquinones | 1 | 2005 | 198 | 0.010 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2006 | 428 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 11872 | 0.010 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2005 | 195 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1999 | 8045 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9547 | 0.010 |
Why?
|
Lactams, Macrocyclic | 1 | 2005 | 319 | 0.010 |
Why?
|
Muramidase | 1 | 1983 | 163 | 0.010 |
Why?
|
Spleen | 1 | 2009 | 2295 | 0.010 |
Why?
|
Epoprostenol | 1 | 1984 | 246 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2015 | 5143 | 0.010 |
Why?
|
United States | 1 | 2011 | 72951 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2006 | 750 | 0.010 |
Why?
|
Pharynx | 1 | 2005 | 436 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1991 | 1203 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2004 | 475 | 0.010 |
Why?
|
Pulmonary Alveoli | 1 | 2005 | 665 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36567 | 0.010 |
Why?
|
Staphylococcal Protein A | 1 | 1982 | 39 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 1984 | 512 | 0.010 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2005 | 422 | 0.010 |
Why?
|
Culture Media | 1 | 1984 | 893 | 0.010 |
Why?
|
Chemistry | 1 | 1982 | 327 | 0.010 |
Why?
|
Melanoma, Experimental | 1 | 2005 | 557 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1982 | 485 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59550 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2000 | 10745 | 0.010 |
Why?
|
Interferons | 1 | 2005 | 714 | 0.010 |
Why?
|
Serum Albumin, Bovine | 1 | 1982 | 319 | 0.010 |
Why?
|
Chromatography, Affinity | 1 | 1982 | 524 | 0.010 |
Why?
|
Lung Diseases | 1 | 1991 | 1941 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2009 | 3158 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10823 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1986 | 3587 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1983 | 1697 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2004 | 1617 | 0.010 |
Why?
|
Egtazic Acid | 1 | 1980 | 165 | 0.010 |
Why?
|
Caspase 7 | 1 | 1999 | 51 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 1982 | 1168 | 0.010 |
Why?
|
Cations, Divalent | 1 | 1980 | 167 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29948 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1150 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14471 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1985 | 3093 | 0.010 |
Why?
|
Doxorubicin | 1 | 2005 | 2229 | 0.010 |
Why?
|
Lipid Bilayers | 1 | 2000 | 376 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2009 | 2747 | 0.010 |
Why?
|
Antigens | 1 | 1983 | 1441 | 0.010 |
Why?
|
Magnetics | 1 | 2000 | 586 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1982 | 3053 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14652 | 0.010 |
Why?
|
Sepsis | 1 | 1991 | 2604 | 0.010 |
Why?
|
RNA, Viral | 1 | 2005 | 2867 | 0.010 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1996 | 205 | 0.010 |
Why?
|
Magnesium | 1 | 1980 | 815 | 0.010 |
Why?
|
Lung Diseases, Interstitial | 1 | 2005 | 939 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1996 | 222 | 0.010 |
Why?
|
Biopsy | 1 | 1987 | 6779 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3721 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1996 | 816 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2000 | 2478 | 0.010 |
Why?
|
Disease Outbreaks | 1 | 2005 | 1761 | 0.010 |
Why?
|
Young Adult | 2 | 2012 | 59939 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2000 | 1969 | 0.010 |
Why?
|
Encephalitis | 1 | 1998 | 441 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 1982 | 1429 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1998 | 2275 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 1983 | 1805 | 0.010 |
Why?
|
Ligands | 1 | 2000 | 3275 | 0.010 |
Why?
|
Hemorrhage | 1 | 2005 | 3464 | 0.010 |
Why?
|
Pregnancy | 1 | 1995 | 30237 | 0.010 |
Why?
|
Calcium | 2 | 1984 | 5783 | 0.010 |
Why?
|
Brain | 1 | 1998 | 27159 | 0.010 |
Why?
|
Skin Diseases, Infectious | 1 | 1991 | 75 | 0.010 |
Why?
|
Coated Pits, Cell-Membrane | 1 | 1989 | 74 | 0.010 |
Why?
|
Meningitis | 1 | 1991 | 219 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 1989 | 323 | 0.010 |
Why?
|
Microglia | 1 | 1998 | 1370 | 0.000 |
Why?
|
Endocarditis, Bacterial | 1 | 1991 | 436 | 0.000 |
Why?
|
Buffers | 1 | 1986 | 141 | 0.000 |
Why?
|
Phospholipases A2 | 1 | 1986 | 197 | 0.000 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1986 | 96 | 0.000 |
Why?
|
Subcellular Fractions | 1 | 1986 | 526 | 0.000 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1988 | 891 | 0.000 |
Why?
|
Sulfhydryl Compounds | 1 | 1986 | 296 | 0.000 |
Why?
|
Cytochalasin B | 1 | 1984 | 74 | 0.000 |
Why?
|
Calcimycin | 1 | 1984 | 214 | 0.000 |
Why?
|
Thromboxane B2 | 1 | 1984 | 143 | 0.000 |
Why?
|
Zymosan | 1 | 1984 | 134 | 0.000 |
Why?
|
Complement C5a, des-Arginine | 1 | 1983 | 4 | 0.000 |
Why?
|
Immunodiffusion | 1 | 1983 | 141 | 0.000 |
Why?
|
Models, Biological | 1 | 2000 | 9461 | 0.000 |
Why?
|
Cytoplasmic Granules | 1 | 1986 | 574 | 0.000 |
Why?
|
Alprostadil | 1 | 1983 | 86 | 0.000 |
Why?
|
Membrane Potentials | 1 | 1986 | 1085 | 0.000 |
Why?
|
Acute Disease | 1 | 1991 | 7241 | 0.000 |
Why?
|
Cyclic AMP | 1 | 1984 | 1472 | 0.000 |
Why?
|
Vasculitis | 1 | 1983 | 528 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1991 | 12985 | 0.000 |
Why?
|
Infant | 1 | 1998 | 36461 | 0.000 |
Why?
|
Child, Preschool | 1 | 1998 | 42577 | 0.000 |
Why?
|
Child | 1 | 1998 | 80668 | 0.000 |
Why?
|
Adolescent | 1 | 1998 | 88904 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1991 | 81635 | 0.000 |
Why?
|